alovudine has been researched along with Bone Cancer in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blanchet, EM; Chen, CC; Herscovitch, P; Martucci, V; Millo, C; Pacak, K | 1 |
| Benz, MR; Buck, AK; Herrmann, K; Pomykala, KL; Wieder, HA | 1 |
| Boerman, OC; Fleuren, ED; Flucke, UE; Franssen, GM; Houghton, PJ; Oyen, WJ; Roeffen, MH; van der Graaf, WT; Versleijen-Jonkers, YM | 1 |
| Benz, MR; Czernin, J; Eilber, FC; Federman, N; Tap, WD; Tchekmedyian, N | 1 |
| Berriolo-Riedinger, A; Brunotte, F; Cochet, A; Couturier, O; Girault, S; Rousseau, C | 1 |
2 review(s) available for alovudine and Bone Cancer
| Article | Year |
|---|---|
PET tracers in musculoskeletal disease beyond FDG.
Topics: Amino Acids; Bone Diseases; Bone Neoplasms; Carbon Radioisotopes; Choline; Dideoxynucleosides; Fluorine Radioisotopes; Humans; Musculoskeletal Diseases; Neoplasms; Positron-Emission Tomography | 2014 |
Utilization of positron emission tomography in the management of patients with sarcoma.
Topics: Bone Neoplasms; Dideoxynucleosides; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Osteosarcoma; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma | 2009 |
3 other study(ies) available for alovudine and Bone Cancer
| Article | Year |
|---|---|
Multitracer PET imaging of bone metastases from paraganglioma: peripheral halo of uptake on 18F-FLT PET mismatching with central uptake of 18F-FDOPA, 18F-fluorodopamine, and 18F-FDG.
Topics: Adrenal Gland Neoplasms; Aged; Biological Transport; Bone Neoplasms; Dideoxynucleosides; Dihydroxyphenylalanine; Dopamine; Fluorodeoxyglucose F18; Humans; Male; Paraganglioma; Positron-Emission Tomography; Radioactive Tracers | 2013 |
Temsirolimus combined with cisplatin or bevacizumab is active in osteosarcoma models.
Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Bone Neoplasms; Cell Line, Tumor; Cisplatin; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Osteosarcoma; Positron-Emission Tomography; Protein Kinase Inhibitors; Sirolimus; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays | 2014 |
Bone metastasis of a breast cancer detected by 3'-deoxy-3'-18F-fluorothymidine PET/CT.
Topics: Adult; Bone and Bones; Bone Neoplasms; Breast Neoplasms; Dideoxynucleosides; Docetaxel; Epirubicin; Female; Humans; Positron-Emission Tomography; Taxoids; Tomography, X-Ray Computed; Treatment Outcome | 2009 |